4-甲烷磺酰苯硼酸 | 166386-48-7

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲烷磺酰苯硼酸
• 中文别名: 4-甲烷磺酰基苯硼酸
• 英文名称: 4-(methylsulfinyl)phenylboronic acid
• 英文别名: 4-(methanesulfinyl)benzeneboronic acid；(4-(Methylsulfinyl)phenyl)boronic acid；(4-methylsulfinylphenyl)boronic acid
• CAS: 166386-48-7
• 化学式: C₇H₉BO₃S
• mdl: MFCD02093071
• 分子量: 184.024
• InChiKey: YOTGALZTDVXUKZ-UHFFFAOYSA-N

物化性质

• 熔点：
  178-180°C
• 沸点：
  416.8±47.0 °C(Predicted)
• 密度：
  1.37±0.1 g/cm3(Predicted)
• 稳定性/保质期：
  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  0.22
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  76.7
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 危险性防范说明：
  P264,P302+P352,P304+P340,P305+P351+P338,P332+P313,P337+P313
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Methylsulfinylphenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Methylsulfinylphenylboronic acid
CAS number: 166386-48-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H9BO3S
Molecular weight: 184.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  4-甲硫基苯硼酸	(4-thiomethoxyphenyl)boronic acid	98546-51-1	C7H9BO2S	168.024

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  4-甲硫基苯硼酸	(4-thiomethoxyphenyl)boronic acid	98546-51-1	C7H9BO2S	168.024

反应信息

• 作为反应物：
  描述：

  4-甲烷磺酰苯硼酸 在 四(三苯基膦)钯 、 sodium acetate 、 三乙酰氧基硼氢化钠 、 potassium carbonate 、 对甲苯磺酸 、 sodium hydrogensulfite 、 溶剂黄146 作用下， 以 1,4-二氧六环 、 甲醇 、 水 、 二甲胺 、 1,2-二氯乙烷 为溶剂， 反应 52.0h， 生成 5,7-dimethoxy-2-(6-(1-methylazetidin-3-yloxy)-4'-(methylsulfinyl)biphenyl-3-yl)quinazolin-4(3H)-one
  参考文献：
  名称：

  BIARYL DERIVATIVES AS BROMODOMAIN INHIBITORS

  摘要：

  本公开涉及一种化合物，该化合物通过结合溴结构域来抑制BET蛋白的功能，并且其在治疗中的应用。

  公开号：

  US20140140956A1
• 作为产物：
  描述：

  4-甲硫基苯硼酸 在 dichlorodioxobis(triphenylphosphineoxide)molybdenum(VI) 、 四丁基硝酸铵 、 copper(II) nitrate 作用下， 以 乙腈 为溶剂， 反应 10.0h， 以99%的产率得到4-甲烷磺酰苯硼酸
  参考文献：
  名称：

  钼-铜催化体系促进的硝酸盐对硫醚和硫代芳烷硼烷的选择性硫氧化

  摘要：

  钼酶催化还原硝酸盐在氮的全球生物循环中起着核心作用。然而，在合成有机化学中使用硝酸盐作为氧化剂非常有限，并且通常需要非常强的酸性和其他极端反应条件。我们已经开发出一种高度化学选择性和高效的催化方法，用于使用硝酸盐作为氧化剂对含硼酸或硼酸酯官能团的硫醚和芳基硫醚进行硫氧化。该均相催化反应在乙腈中进行，其中MoO 2 Cl 2（OPPh 3）2配合物1或配合物1与Cu（NO 3）的混合物2用作催化剂。我们使用1 H，15 N和31 P NMR技术以及18 O标记的硝酸钠（NaN 18 O 3）检查了反应机理，结果表明硫醚被硝酸盐氧化，生成亚硝酸盐。我们的工作增加了有机硼化合物现有的化学转化方法，使人们可以直接接触各种可能适用于铃木交叉偶联化学的新底物。

  DOI：

  10.1021/jo2001808

文献信息

• B(C₆ F₅ )₃ -Catalyzed Deoxygenation of Sulfoxides and Amine <i>N</i> -Oxides with Hydrosilanes
  作者：Fangwei Ding、Yanqiu Jiang、Shaoyan Gan、Robert Li-Yuan Bao、Kaifeng Lin、Lei Shi

  DOI：10.1002/ejoc.201700489

  日期：2017.6.30

  An efficient strategy for the deoxygenation of sulfoxides and amine N-oxides using B(C6F5)3 and hydrosilanes has been developed. The method affords the corresponding aromatic or aliphatic products in good to high yields, and shows good functional group tolerance under mild conditions.

  已开发出一种使用 B(C6F5)3 和氢硅烷对亚砜和胺 N-氧化物进行脱氧的有效策略。该方法以良好到高产率提供相应的芳族或脂肪族产物，并且在温和条件下显示出良好的官能团耐受性。
• [EN] MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE MCL-1 MACROCYCLIQUE ET PROCÉDÉS D'UTILISATION
  申请人：ABBVIE INC

  公开号：WO2019035927A1

  公开（公告）日：2019-02-21

  The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).

  本公开提供了Formula (I)中A2、A3、A4、A6、A7、A8、A15、RA、R5、R9、R10A、R10B、R11、R12、R13、R14、R16、W、X和Y的化合物，这些化合物的任何值均在规范中定义，并且其药学上可接受的盐，可用作治疗疾病和病况，包括癌症的药物。还提供了包含Formula (I)中化合物的药物组合物。
• [EN] MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO<br/>[FR] MODULATEURS DU RÉCEPTEUR GPR119 ET TRAITEMENT DE TROUBLES QUI LUI SONT ASSOCIÉS
  申请人：ARENA PHARM INC

  公开号：WO2012135570A1

  公开（公告）日：2012-10-04

  The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single agent or in combination with one or more pharmaceutical agents, such as, an inhibitor of DPP-IV, a biguanide, or an alpha-glucosidase inhibitor, in the treatment of, for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing a blood incretin level; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto.

  本发明涉及式(Ia)化合物以及药用可接受的盐、溶剂化物和水合物，它们作为单一药剂或与一个或多个药物制剂如DPP-IV抑制剂、双胍类药物或α-葡萄糖苷酶抑制剂联合使用，在例如治疗以下疾病中有用：GPR119受体相关疾病；通过增加血液中肠促胰岛素水平而改善的状况；代谢相关疾病；2型糖尿病；肥胖；及其相关并发症。
• A chemoselective ipso-hydroxylation of arylboronic acids using urea-hydrogen peroxide under catalyst free condition
  作者：Surabhi Gupta、Priyanka Chaudhary、Vandana Srivastava、Jeyakumar Kandasamy

  DOI：10.1016/j.tetlet.2016.04.099

  日期：2016.6

  An efficient and practical method for the chemoselective ipso-hydroxylation of arylboronic acids is demonstrated using urea-hydrogen peroxide under catalyst free condition at room temperature. Remarkably, oxidation sensitive functional groups such as olefin, aldehyde, alcohol, ketone, and sulfide as well as heterocycles such as pyridine and thiophene were tolerated under the standard reaction condition

  在室温下，在无催化剂条件下，使用过氧化氢-尿素氢，证明了芳基硼酸化学选择性的ipso-羟基化反应的有效方法。值得注意的是，在标准反应条件下可以耐受对氧化敏感的官能团（例如烯烃，醛，醇，酮和硫化物）以及杂环（例如吡啶和噻吩）。除溶液相外，还用过氧化氢尿素研究了芳基硼酸的固相ipso-羟基化。讨论了固相协议的范围和局限性。
• [EN] TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF<br/>[FR] INHIBITEURS DE LA KINASE TRKA, COMPOSITIONS EN CONTENANT ET MÉTHODES ASSOCIÉES
  申请人：MERCK SHARP & DOHME

  公开号：WO2016054807A1

  公开（公告）日：2016-04-14

  The present invention is directed to substituted indole compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, adisease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

  本发明涉及式(I)的取代吲哚化合物，它们是肌动蛋白相关激酶（Trk）家族蛋白激酶抑制剂，因此在治疗与神经生长因子（NGF）受体TrkA异常活动相关的疼痛、炎症、癌症、再狭窄、动脉粥样硬化、牛皮癣、血栓形成、疾病、紊乱、损伤或与失髓鞘或脱髓鞘相关的疾病或紊乱方面具有用处。